Clinical Trial Update: Treatment of Moderate Vein Graft Lesions With Paclitaxel Drug Eluting Stents: The VELETI Trial [Phase 4]

View source ↗

Summary

The VELETI trial, a Phase 4 study evaluating paclitaxel-eluting strategies for moderate vein graft lesions in patients after coronary artery bypass grafting, ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Laval University | Conditions: Coronary Artery Bypass Grafting | Phase 4 | Status: COMPLETED